Amgen’s headquarters is in Thousand Oaks, Calif., but it’s still the biggest single biotech employer in the Puget Sound area, eclipsing even home-grown ICOS. So the company’s decision to buy back $5 billion in its own stock is big news. http://today.reuters.com/news/newsArticle.aspx?type=businessNews&storyID=2005-12-07T153549Z_01_YUE756085_RTRUKOC_0_US-AMGEN.xml&archived=False or http://abcnews.go.com/Business/wireStory?id=1381452 or http://biz.yahoo.com/ap/051207/amgen_buyback_program.html?.v=1
The company said the move reflects its “long-term confidence” in its business. The stock ended trading Wednesday, by the way, at $79.01 a share, down 77 cents.